Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

South African HIV self-testing policy and guidance considerations.

Venter F, Majam M, Jankelowitz L, Adams S, Moorhouse M, Carmona S, Stevens W, Msimanga BR, Allen D, Balani P, Nevhutalu Z, Rhagnath N, Shroufi A, Devillé W, Kazangarare V, van der Wiel R, Templeman H, Puren A, Tucker T, van Cutsem G, Conradie F, Dong K, Chidarikire T, Gray A.

South Afr J HIV Med. 2017 Sep 22;18(1):775. doi: 10.4102/sajhivmed.v18i1.775. eCollection 2017.

2.

Candidates for inclusion in a universal antiretroviral regimen: are lamivudine and emtricitabine interchangeable?

Ford N, Vitoria M, Doherty M, Gray A.

Curr Opin HIV AIDS. 2017 Jul;12(4):334-338. doi: 10.1097/COH.0000000000000377. Review.

PMID:
28403026
3.

Revision of the International Pharmaceutical Federation's Basel Statements on the future of hospital pharmacy: From Basel to Bangkok.

Vermeulen LC, Moles RJ, Collins JC, Gray A, Sheikh AL, Surugue J, Moss RJ, Ivey MF, Stevenson JG, Takeda Y, Ranjit E, Chaar B, Penm J.

Am J Health Syst Pharm. 2016 Jul 15;73(14):1077-86. doi: 10.2146/ajhp150641. Epub 2016 May 17.

PMID:
27189856
4.

Health Care and Pharmacy Practice in South Africa.

Gray A, Riddin J, Jugathpal J.

Can J Hosp Pharm. 2016 Jan-Feb;69(1):36-41. No abstract available.

5.

Cost-minimization analysis of imipenem/cilastatin versus meropenem in moderate to severe infections at a tertiary care hospital in Saudi Arabia.

Joosub I, Gray A, Crisostomo A, Salam A.

Saudi Pharm J. 2015 Nov;23(6):626-34. doi: 10.1016/j.jsps.2015.02.016. Epub 2015 Feb 28.

6.

Essential medicines are still essential.

Gray AL, Wirtz VJ, 't Hoen EF, Reich MR, Hogerzeil HV.

Lancet. 2015 Oct 24;386(10004):1601-3. doi: 10.1016/S0140-6736(15)00514-0. No abstract available.

PMID:
26595616
7.

Conflict of interest and regulatory authorities.

Jobson R, Gray A.

S Afr Med J. 2015 Mar;105(3):164. No abstract available.

PMID:
26294835
8.

Initiative to progress research on medicine utilization in Africa: formation of the Medicines Utilization Research in Africa group.

Massele A, Godman B, Adorka M, Fadare J, Gray A, Lubbe M, Ogunleye O, Truter I.

Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):607-10. doi: 10.1586/14737167.2015.1065735. No abstract available.

PMID:
26176752
9.

The Darwin Awards: sex differences in idiotic behaviour.

Lendrem BA, Lendrem DW, Gray A, Isaacs JD.

BMJ. 2014 Dec 11;349:g7094. doi: 10.1136/bmj.g7094.

10.

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

Godman B, Malmström RE, Diogene E, Gray A, Jayathissa S, Timoney A, Acurcio F, Alkan A, Brzezinska A, Bucsics A, Campbell SM, Czeczot J, de Bruyn W, Eriksson I, Yusof FA, Finlayson AE, Fürst J, Garuoliene K, Guerra Júnior A, Gulbinovič J, Jan S, Joppi R, Kalaba M, Magnisson E, McCullagh L, Miikkulainen K, Ofierska-Sujkowska G, Pedersen HB, Selke G, Sermet C, Spillane S, Supian A, Truter I, Vlahović-Palčevski V, Vien LE, Vural EH, Wale J, Władysiuk M, Zeng W, Gustafsson LL.

Expert Rev Clin Pharmacol. 2015 Jan;8(1):77-94. doi: 10.1586/17512433.2015.990380. Review.

PMID:
25487078
11.

AGREE to disagree: critical appraisal and the publication of practice guidelines.

Wiseman R, Cohen K, Gray A, Jamaloodien K, Kredo T, Miot J, Parrish A, Taylor B, Blockman M.

S Afr Med J. 2014 Apr 9;104(5):345-6. doi: 10.7196/samj.8215.

PMID:
25212200
12.

Medicines shortages-unpicking the evidence from a year in South Africa.

Gray A.

Australas Med J. 2014 May 31;7(5):208-12. doi: 10.4066/AMJ.2014.1932. eCollection 2014.

13.

The future of medicines use and access research: using the Journal of Pharmaceutical Policy and Practice as a platform for change.

Babar ZU, Gray A, Kiani A, Vogler S, Ballantyne P, Scahill S.

J Pharm Policy Pract. 2014 Jul 8;7:8. doi: 10.1186/2052-3211-7-8. eCollection 2014. No abstract available.

14.

Comparative efficacy of Lamivudine and emtricitabine: a systematic review and meta-analysis of randomized trials.

Ford N, Shubber Z, Hill A, Vitoria M, Doherty M, Mills EJ, Gray A.

PLoS One. 2013 Nov 11;8(11):e79981. doi: 10.1371/journal.pone.0079981. eCollection 2013. Review.

15.

The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.

Lutge EE, Gray A, Siegfried N.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD005175. doi: 10.1002/14651858.CD005175.pub3. Review.

PMID:
23633327
16.

Shortages of medicines: a complex global challenge.

Gray A, Manasse HR Jr.

Bull World Health Organ. 2012 Mar 1;90(3):158-158A. doi: 10.2471/BLT.11.101303. No abstract available.

17.

WHO Essential Medicines List for Children: impact on patient outcomes?

Gray A.

Paediatr Drugs. 2011 Aug 1;13(4):209-11. doi: 10.2165/11589090-000000000-00000. No abstract available.

PMID:
21391732
18.

Surveillance of antimicrobial resistance in resource-constrained settings - experience from five pilot projects.

Holloway K, Mathai E, Gray A; Community-Based Surveillance of Antimicrobial Use and Resistance in Resource-Constrained Settings Project Group.

Trop Med Int Health. 2011 Mar;16(3):368-74. doi: 10.1111/j.1365-3156.2010.02696.x. Epub 2010 Dec 8.

19.

Surveillance of community antimicrobial use in resource-constrained settings--experience from five pilot projects.

Holloway K, Mathai E, Gray A; Community-Based Surveillance of Antimicrobial Use and Resistance in Resource-Constrained Settings Project Group.

Trop Med Int Health. 2011 Feb;16(2):152-61. doi: 10.1111/j.1365-3156.2010.02695.x. Epub 2010 Dec 8.

20.

Home self-testing for HIV: AIDS exceptionalism gone wrong.

Richter M, Venter WD, Gray A.

S Afr Med J. 2010 Oct 1;100(10):636-42. No abstract available.

PMID:
21081002
21.

Pediatric pharmacotherapy issues in Africa.

Gray A.

Paediatr Drugs. 2009;11(1):6-8.

PMID:
19127941
22.

Hormone therapy use in the South African public and private sectors 2001-2005.

Podmore SH, Botha JH, Gray AL.

Maturitas. 2008 Jun 20;60(2):182-4. doi: 10.1016/j.maturitas.2008.04.008. Epub 2008 Jun 2. No abstract available.

PMID:
18514446
23.

Setting standards for essential children's medicines.

Hill SR, Gray A, Weber M.

Bull World Health Organ. 2007 Sep;85(9):650. No abstract available.

24.
25.

25 years of the WHO essential medicines lists: progress and challenges.

Laing R, Waning B, Gray A, Ford N, 't Hoen E.

Lancet. 2003 May 17;361(9370):1723-9. Review.

PMID:
12767751

Supplemental Content

Loading ...
Support Center